2

Vive Summary• Vive reformulates existing pesticides for the $46 Billion crop

protection industry, addressing issues jeopardizing the industry

• Replace organic solvents with biodegradable or bio-inert polymers

• Working with six global crop protection companies on products with $8 billion total addressable market

• Six products in field trials with results expected by year end

• Trials demonstrate Vive formulations are more effective than current products

• Products and process are patented and are 100% owned

• Experienced management team and advisors

• Raised $16 MM to date

3

Crop Yields are a Worldwide Issue • Population growth• Shrinking arable land• Changing diets• Biofuels

$46Bpesticide industry

The Growing Use of Pesticides is Assured

Yet Industry Profits are Under Pressure

Patent Cliff

Lack ofNew Molecules

RegulatoryBarriers

Crop Protection IndustrySyngenta | Bayer | BASF | DuPont | Dow

Pressure from Generics4

Addressing Crop Protection Industry’s Key Issues

Patentable Competitive Approvable

• New IP without new active ingredient

• Economics• Efficacy• Convenience• Grower safety

• Avoid toxic formulations

• Environmental safety

5

Products

Vive Patented Technology Platform

IP Generating Innovative Approvable

• Broadly applicable reformulation technology

• Lower development cost per product

• Improves economics, efficacy, safety, convenience

• Fast timelines

• Improves handling and safety

• Enables water to act as the only solvent

6

Active Ingredient (AI) Vive Cage Vive New Product

Vive Technology

Not soluble in water Encapsulates AI in a water dispersible (non-toxic) structure

Encapsulated AIdispersed in water

77

8

Vive Technology Platform

Water and bio-inert polymers create a cage that delivers the active ingredient

• Low capital cost — uses off the shelf equipment

• Main inputs are EPA approved polymers

• Straightforward path to large commercial scale

• $4 MM capex for 200T Allosperse plant

Pilot Scale Plant (Five tonnes per year)

Simple, Scalable Manufacturing

99

10

6,000 Tonnes of packaged

product with >$100 MM in

annual revenue

Vive 200 Tonne plant

Low Capex with Significant Product Leverage

600 Tonnes of partner supplied active ingredient

• 12 issued patents (first expiry 2017)

• 52 patents pending

• 7 families in the US and internationally

• New products via patentable reformulations

• First reformulated product patents to be filed in 2012

Four Levels of IP Protection

Patent Cliff

Ongoing IP Generation11

Product IP

Application IP

Process IP

Composition of Matter IP

Patented Actives Generic Actives

• Developing products with branded companies

• $5 Billion+ addressable market

• Upfront, milestone and royalty revenue

• Developing products to be distributed through branded companies

• $3 Billion+ addressable market

• Product revenue

Portfolio Renewal and Extension Model12

Vive Product Portfolio

Partnered Product

13

Improved Insecticide Efficacy

Treatment Pests Killed

Plant Damage(Lower is Better)

Vive 90% 1.1%

Ammo 5% 32.5%

• Third party trials tested Vive’s formulated cypermethrin versus the leading competitive product, FMC’s Ammo

• Both products were applied at 0.1ppm

• Tests demonstrated superior performance killing pests and protecting plants

• Results have been confirmed in 5 different trials

What Does it Mean to the Farmer?

Potential product benefits include:

• Better plant protection – higher yields

• Buy and use less pesticide – save money

Vive’s formulation was 18x more effective killing pests and ~30x more effective protecting plants from insect damage

Partnered Product

14

Improved Residual Activity• Trials test how long a product keeps working after

it is applied

• Third party trials tested Vive’s formulated lambda-cyhalothrin versus the leading premium product, Syngenta’s Karate Zeon, at identical concentrations

• Karate Zeon is marketed against “standard” products based on its superior residual activity

• Results show that Vive’s formulation is better after 7 and 14 days

What Does it Mean to the Farmer?

Potential product benefits include:

• Sustained protection – higher yields, better crops

• Apply less often – save money and hassle

Treatment Pests Killed7 Days Later

Pests Killed14 Days Later

Vive 90% 76%

Karate Zeon 50% 42%

Vive’s formulation was 80% more effective killing pests both one and two weeks after application

15

Potential Markets

Pharmaceuticals

TAM => $500 Bn

Beauty and Personal CareTAM => $425

Bn

Crop ProtectionTAM => $50 Bn

NutritionalsTAM => $100

Bn

IndustrialTAM => $300

Bn

Potential Markets > $1 Trillion

Corporate Information

16

Keith ThomasCEO

Entrepreneur, project management and corporate finance; Booz Allen, Citigroup, BASc (Toronto), MA (Toronto), MBA (Columbia)

Darren AndersonCTO

Founding president, 4 issued patents, 24 pending applications, 10 refereed papers, over 40 conference presentations and publications, PhD (Toronto)

Flavio CampagnaroVP Manufacturing

Senior process engineer, scaled large environmental plants; Bennett Environmental, BASc (UBC), PEng

Skip CampbellVP Product Creation

Boston-based M&A and advisory for high-tech industries, consulting and VC experience, BA (Williams), MBA (Toronto)

Ken YoonCFO and VP Corp Development

Life sciences venture capitalist, consulting and accounting; VenGrowth, Ernst & Young, BSc (Western), LLB (Queen’s), MBA (Toronto), CA

Management

17

Supplemented by 10 advisors with experience at Syngenta, BASF, DuPont, Dow, FMC ,etc.

Neil ReidChair Co-founder, MDS Sciex

Charlie FischerDirector

Former CEO, Dow AgroSciences; Former Chair, CropLife America and CropLife International

Warren LibbyDirector

Former President, Syngenta Canada; Former Chairman, Crop Protection Institute of Canada

Bill LambertDirector Chairman, Ag Growth International; Former Partner, TD Capital

Mark MacDonaldDirector Former VP, Teachers Private Equity; significant board experience

Directors

181818

19

The Vive Opportunity

$46 Billion global market opportunity with assured demand with

significant potential in additional markets

Patent cliff, formulation issues and generics are unavoidable

Disruptive, patented, green technology addresses industry needs

Products with $8 Billion addressable market in dev and trials

Strong management team and directors

Commercial deals in 2013 and product launches in 2014